Abstract: A liquid crystal phase shifter includes: a first substrate; a second substrate, provided opposite to the first substrate; a liquid crystal layer, provided between the first substrate and the second substrate; and a phase shift region, including a first electrode, a second electrode and a control circuit, where the first electrode is provided on a side of the first substrate close to the second substrate, the second electrode is provided on a side of the second substrate close to the first substrate, an orthographic projection of the second electrode on the first substrate partially overlaps with an orthographic projection of the first electrode on the first substrate, and the second electrode is grounded.

Abstract: A flexible OLED display device includes a flexible display panel and a support member. The flexible display panel includes an active area, an extension portion and a bending portion connecting the active area and the extension portion. The support member is located between the active area and the extension portion. The active area, the support member and the extension portion are stacked, and a predetermined distance is set between the support member and the bending portion in an extending direction parallel to the extension portion.

Abstract: A gene chip includes a chip carrier, a plurality of DNA nanoballs assembled on the chip carrier, and a polymer film formed on the chip carrier and wrapping the DNA nanoballs. The polymer film includes at least one of a film of a positively charged polymer, a film of a positively charged polymer which is modified, a film of a zwitterionic polymer, and a composite polymer film. The composite polymer film is formed by a layer-by-layer self-assembly process of a positively charged polymer and a negatively charged polymer. The gene chip has good sequencing quality and different functions can be achieved by coating with different polymers, such as the chip surface rapidly drying out and surface non-specific adsorption. A method of preparing a gene chip is further disclosed.

Abstract: A grating regulating device includes: a first substrate, a conductive layer, a dielectric layer and a second substrate arranged in stack, the conductive layer includes a wiring layer, a first insulating layer and a first electrode layer arranged in stack, the wiring layer includes a plurality of driving lines, and the first electrode layer includes a plurality of sub-electrodes arranged in a first direction. The driving lines are for transmitting a driving signal to the sub-electrodes, and the sub-electrodes are for, by the effect of the driving signal, driving corresponding positions of the dielectric layer to be light-transmitting or opaque. The grating regulating device includes a grating region including a plurality of common-signal units, each of the common-signal units includes at least one grating unit, the grating unit includes a plurality of sub-electrodes, and the plurality of sub-electrodes located in the same grating unit are connected to different driving lines.

Abstract: A tunable phase shifter and a method for manufacturing the same, and a tunable phase shifting device. The phase shifter includes a first substrate, a second substrate, and a tunable dielectric layer between the first substrate and the second substrate; the first substrate includes a first base substrate and a first electrode on the first base substrate; the second substrate includes a second base substrate and a second electrode on the second base substrate; an orthographic projection of the first electrode on the first base substrate is at least partially overlapped with an orthographic projection of the second electrode on the first base substrate, and sheet resistances of materials of the first electrode and the second electrode are both less than or equal to 0.024?/?.

Abstract: A display device, including a backlight module (1). The backlight module (1) includes an optical film layer (2), the optical film layer (2) includes at least two diffusers (21) stacked in sequence, and the haze of each diffuser (21) is 80%-99%. The backlight module (1) further includes an LED light source (3), and the optical band of the LED light source (3) is greater than 455 nm. The display device further includes a cover plate (5) and at least one anti-reflection layer (7), the cover plate (5) is provided with an atomization layer (51), and the anti-reflection layer (7) is located on the side of the cover plate (5) facing away from a display panel (4).

Abstract: A grating adjustment apparatus includes a first electrode layer, a second electrode layer and a first substrate and a second substrate that are opposite to each other; the grating adjustment apparatus further includes a plurality of first driving lines, a plurality of second driving lines and a plurality of grating units arranged in the first direction, and is configured as: when the grating adjustment apparatus is powered on, the grating unit is capable of forming a light transmission unit and a shading unit, and opening positions and/or opening ratios of the grating unit are adjustable; and the plurality of grating units are divided into at least one group; for the grating units in the same group, at least two of the first sub-electrodes are electrically connected to different first driving lines, and at least two of the second sub-electrodes are electrically connected to different second driving lines.

Abstract: Provided in the present invention is an antibody against human CD3 or an antigen-binding fragment thereof; also provided are a nucleic acid molecule encoding the antibody, an expression vector expressing the antibody and a host cell, as well as a method for producing the antibody. In addition, also provided in the present invention are a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof, a use thereof in the preparation of a drug, and a use of the drug as a drug for the prevention and/or treatment of various diseases, including tumors, organ transplantation and autoimmune diseases.

Abstract: The present disclosure relates to a dual-function protein for regulating blood glucose and lipid metabolism, wherein said dual-function protein comprises a human GLP-1 analog and human FGF21. In the present disclosure, provided is a method for preparing said dual function protein, and also provided is the use of said dual-function protein in the preparation of a biological substance for treating type 2 diabetes, obesity, dyslipidemia, fatty liver disease and/or metabolic syndrome. The dual-function protein provided in the present disclosure can synergistically regulate blood glucose and lipid levels in vivo, and satisfy multiple requirements for patients with type 2 diabetes such as lowering blood glucose, relieving hepatic steatosis, reducing body weight and improving metabolic disorders of circulating lipids.

Abstract: A projection device and a keystone correction method thereof are provided. The keystone correction method is adapted for the projection device and includes the following steps. A first image is obtained. A first line-taking position parameter is determined according to a ratio of a first target edge length to a second target edge length. At least one line of input pixels disposed in a first direction is retrieved from the first image according to the first line-taking position parameter. A first scaling process related to the first direction is performed according to at least one line of input pixels of the first image, such that a line of output pixels of a second image disposed in the first direction is generated. The projection device projects the second image onto a projection screen to display a rectangular projected image.

Abstract: A touch display substrate is provided, including a central touch area and a routing area located around the central touch area, where the routing area is provided with isolation lines and a plurality of touch signal lines led out from the central touch area, the extension direction of the isolation lines is parallel to the extension direction of the touch signal lines, the touch signal lines include first touch signal lines arranged close to the isolation lines and second touch signal lines arranged far from the isolation lines, and the width of the first touch signal lines is greater than the width of the second touch signal lines. A touch display device and a touch control signal line distribution method are provided.

Abstract: A grating adjustment apparatus includes a first electrode layer, a second electrode layer and a first substrate and a second substrate that are opposite to each other; the grating adjustment apparatus further includes a plurality of first driving lines, a plurality of second driving lines and a plurality of grating units arranged in the first direction, and is configured as: when the grating adjustment apparatus is powered on, the grating unit is capable of forming a light transmission unit and a shading unit, and opening positions and/or opening ratios of the grating unit are adjustable; and the plurality of grating units are divided into at least one group; for the grating units in the same group, at least two of the first sub-electrodes are electrically connected to different first driving lines, and at least two of the second sub-electrodes are electrically connected to different second driving lines.

Abstract: The present disclosure relates to a dual-function protein for regulating blood glucose and lipid metabolism, wherein said dual-function protein comprises a human GLP-1 analog and human FGF21. In the present disclosure, provided is a method for preparing said dual function protein, and also provided is the use of said dual-function protein in the preparation of a biological substance for treating type 2 diabetes, obesity, dyslipidemia, fatty liver disease and/or metabolic syndrome. The dual-function protein provided in the present disclosure can synergistically regulate blood glucose and lipid levels in vivo, and satisfy multiple requirements for patients with type 2 diabetes such as lowering blood glucose, relieving hepatic steatosis, reducing body weight and improving metabolic disorders of circulating lipids.

Abstract: Systems and methods for mapping cancer classification labels are provided. In a method for generating a cancer label for a cancer patient, the method entails acquiring, from a data source, a cancer classification for a cancer in the cancer patient; extracting, from the cancer classification, primary anatomic site, primary histology, and invasiveness (or behavior) of the cancer; identifying, in a lookup table, an entry having the extracted anatomic site, histology, and invasiveness (or behavior); and retrieving a corresponding cancer label in the entry for the cancer.

Abstract: A display device, including a backlight module (1). The backlight module (1) includes an optical film layer (2), the optical film layer (2) includes at least two diffusers (21) stacked in sequence, and the haze of each diffuser (21) is 80%-99%. The backlight module (1) further includes an LED light source (3), and the optical band of the LED light source (3) is greater than 455 nm. The display device further includes a cover plate (5) and at least one anti-reflection layer (7), the cover plate (5) is provided with an atomization layer (51), and the anti-reflection layer (7) is located on the side of the cover plate (5) facing away from a display panel (4).

Abstract: A linker peptide for constructing a fusion protein. The linker peptide comprises a flexible peptide and a rigid peptide. The flexible peptide consists of one or more flexible units. The rigid peptide consists of one or more rigid units. The flexible unit comprises two or more amino acid residues selected from Gly, Ser, Ala, and Thr. The rigid unit comprises a human chorionic gonadotropin ?-subunit carboxy-terminal peptide (CTP) bearing a plurality of glycosylation sites. The linker peptide can more effectively eliminate mutual steric hindrance of two fusion molecules, decreasing a reduction/loss of polymerization or activity resulting from improper folding of an active protein or a conformational change. On the other hand, the negatively charged, highly sialylated CTP can resist renal clearance, further prolonging a half-life of a fused molecule and enhancing bioavailability of a fused protein.

Abstract: A video switching method includes the following operations: decoding second video data during a period when a panel is driven to display image content corresponding to first video data to generate frame parameter data and image data; and processing the image data according to the frame parameter data in response to a control command to drive the panel to display image content corresponding to the second video data.

Abstract: A touch display substrate is provided, including a central touch area and a routing area located around the central touch area, where the routing area is provided with isolation lines and a plurality of touch signal lines led out from the central touch area, the extension direction of the isolation lines is parallel to the extension direction of the touch signal lines, the touch signal lines include first touch signal lines arranged close to the isolation lines and second touch signal lines arranged far from the isolation lines, and the width of the first touch signal lines is greater than the width of the second touch signal lines. A touch display device and a touch control signal line distribution method are provided.

Abstract: A projection device and a projection picture correction method thereof are provided. When the projection device performs projection toward a projection surface, a plurality of target coordinates of a plurality of target vertexes are obtained based on a plurality of planes of the projection surface. The plurality of planes are not coplanar with each other, and the plurality of target vertexes form a target polygon. A first direction scaling process is performed respectively on a plurality of first image portions of an original trapezoidal image and a trapezoidal image block is generated. A second direction scaling process is performed respectively on a plurality of second image portions of the trapezoidal image block and a target image block aligned with the target polygon is generated. An output image including the target image block is projected onto the projection surface.

Abstract: A linker peptide for constructing a fusion protein. The linker peptide comprises a flexible peptide and a rigid peptide. The flexible peptide consists of one or more flexible units. The rigid peptide consists of one or more rigid units. The flexible unit comprises two or more amino acid residues selected from Gly, Ser, Ala, and Thr. The rigid unit comprises a human chorionic gonadotropin ?-subunit carboxy-terminal peptide (CTP) bearing a plurality of glycosylation sites. The linker peptide can more effectively eliminate mutual steric hindrance of two fusion molecules, decreasing a reduction/loss of polymerization or activity resulting from improper folding of an active protein or a conformational change. On the other hand, the negatively charged, highly sialylated CTP can resist renal clearance, further prolonging a half-life of a fused molecule and enhancing bioavailability of a fused protein.